AAAAAA

   
Results: 1-14 |
Results: 14
ANTICARDIOLIPIN ANTIBODY POSITIVITY IN SUBJECTS SUFFERING FROM DIFFERENT CLINICAL MANIFESTATIONS
Authors: CIAMPA A CANTORE N MANZO A VOLPE E
Citation: A. Ciampa et al., ANTICARDIOLIPIN ANTIBODY POSITIVITY IN SUBJECTS SUFFERING FROM DIFFERENT CLINICAL MANIFESTATIONS, Thrombosis research, 91(3), 1998, pp. 80-80
DETECTION OF ANTIPHOSPHOLIPID ANTIBODIES (APL) ACTIVITY IN THE PATIENTS WITH DIABETES-MELLITUS RELATED VASCULAR ALTERATIONS
Authors: CIAMPA A MANZO A VOLPE E
Citation: A. Ciampa et al., DETECTION OF ANTIPHOSPHOLIPID ANTIBODIES (APL) ACTIVITY IN THE PATIENTS WITH DIABETES-MELLITUS RELATED VASCULAR ALTERATIONS, Thrombosis research, 91(3), 1998, pp. 81-81
SUCCESSFUL ROLE OF TTIT TO PT RATIO IN THE DETECTION OF FALSE-POSITIVE RESULTS IN THE DIAGNOSIS OF LA
Authors: CIAMPA A MANZO A VOLPE E
Citation: A. Ciampa et al., SUCCESSFUL ROLE OF TTIT TO PT RATIO IN THE DETECTION OF FALSE-POSITIVE RESULTS IN THE DIAGNOSIS OF LA, Thrombosis research, 91(3), 1998, pp. 82-82
ASPIRIN AND CALCIUM HEPARIN - A COMPARATIVE-EVALUATION OF BOTH TREATMENTS IN ANTIPHOSPHOLIPID ANTIBODIES (APL) POSITIVE WOMEN WITH RECURRENT PREGNANCY LOSS
Authors: CIAMPA A MANZO A VOLPE E
Citation: A. Ciampa et al., ASPIRIN AND CALCIUM HEPARIN - A COMPARATIVE-EVALUATION OF BOTH TREATMENTS IN ANTIPHOSPHOLIPID ANTIBODIES (APL) POSITIVE WOMEN WITH RECURRENT PREGNANCY LOSS, Thrombosis research, 91(3), 1998, pp. 84-84
EVALUATION OF THE STRONG CORRELATION BETWEEN ANTIPHOSPHOLIPID ANTIBODIES (APL) AND RECURRENT PREGNANCY LOSS
Authors: CIAMPA A MANZO A VOLPE E
Citation: A. Ciampa et al., EVALUATION OF THE STRONG CORRELATION BETWEEN ANTIPHOSPHOLIPID ANTIBODIES (APL) AND RECURRENT PREGNANCY LOSS, Thrombosis and haemostasis, 1997, pp. 1348-1348
DETECTION OF ANTIPHOSPHOLIPID ANTIBODIES (APL) ACTIVITY IN THE PATIENTS WITH DIABETES-MELLITUS RELATED VASCULAR ALTERATIONS
Authors: CIAMPA A VOLPE A VOLPE E
Citation: A. Ciampa et al., DETECTION OF ANTIPHOSPHOLIPID ANTIBODIES (APL) ACTIVITY IN THE PATIENTS WITH DIABETES-MELLITUS RELATED VASCULAR ALTERATIONS, Thrombosis and haemostasis, 1997, pp. 2211-2211
FACTORS THAT PREDICT RESPONSE AND DISEASE-FREE SURVIVAL IN CLINICALLYADVANCED FOLLICULAR LYMPHOMAS
Authors: GENUA A BISCOTTINI B CINIERI S TROTTINI M DERENZO A ROTOLI B TAFUTO S ABATE G MILANI S MUSTACCHI G AMBROSI L LEONI P MASTRIA A LORUSSO V VECCHI A SACCHI S PALMIERI F VOLPE E AZZOLINI C DAMMACCO F DICOSTANZO F CAPARROTTI G GRIGNANI F DEANGELIS V ALSHARJABY N LIBERATI AM
Citation: A. Genua et al., FACTORS THAT PREDICT RESPONSE AND DISEASE-FREE SURVIVAL IN CLINICALLYADVANCED FOLLICULAR LYMPHOMAS, Blood, 90(10), 1997, pp. 842-842
WHICH TREATMENT IS PREFERABLE FOR ANAPLASTIC LARGE-CELL LYMPHOMA-HODGKINS-LIKE (ALCL-HL) - MACHOP-B OR ABVD
Authors: ZINZANI PL MARTELLI M PILERI S VOLPE E GOBBI M GALIENI P AMADORI S LEONE G MORETTI L MAZZA P GHERLINZONI F BENDANDI M DESANCTIS V CARUSO R MANDELLI F TURA S
Citation: Pl. Zinzani et al., WHICH TREATMENT IS PREFERABLE FOR ANAPLASTIC LARGE-CELL LYMPHOMA-HODGKINS-LIKE (ALCL-HL) - MACHOP-B OR ABVD, Blood, 88(10), 1996, pp. 2274-2274
INTERFERON ALFA-2A AS COMPARED WITH CONVENTIONAL CHEMOTHERAPY FOR THETREATMENT OF CHRONIC MYELOID LEUKEMIA
Authors: TURA S BACCARANI M ZUFFA E RUSSO D ZACCARIA A FIACCHINI M TESTONI N ZAMAGNI MD MARTINELLI G DAMIANI D MICHIELI M FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C ALIMENA G MANDELLI F LEONI P DANIELI G NOSARI A DECATALDO F MAJOLINO I CARONIA F LIBERATI AM GRIGNANI F TABILIO A MARTELLI M PAOLINO F RESEGOTTI L DITUCCI A BROCCIA G LEONI F CIOLLI S LUCIANO L ROTOLI B PERRICONE R CAJOZZO A MONTUORO A DELAURENZI A VOLPE E DEMILIO A BATTISTA R CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL LOMBARDO M TORLONTANO G LANDOLFI R LEONE G DELFINI C SPARAVENTI G PAPINESCHI F SPREMOLLA G RISSO M MARMONT AM DINI D DIPRISCO U MANGONI L RIZZOLI V GIRINO M ASCARI E BODENIZZA CA CAROTENUTO M DIFRANCESCO A QUAGLINO D NARDELLI S CICCONE F MIRAGLIA E DEBIASE R GALLO E PILERI A RAMBALDI A BARBUI T MORANDI S BIANCHINI E DEROSA C CIMINO R RONCA F NOBILE F CANTONETTI M PAPA G GALLAMINI A BUFFA F MUSOLINO C SQUADRITO G CAPALDI A GIOVANNELLI E PINOTTI G VENCO A ZAGONEL V PINTO A GENTILINI I COSER P GUGLIELMO P CACCIOLA E PIZZUTI M RICCIUTI F FANIN R CRISCUOLO D MONTEFUSCO E
Citation: S. Tura et al., INTERFERON ALFA-2A AS COMPARED WITH CONVENTIONAL CHEMOTHERAPY FOR THETREATMENT OF CHRONIC MYELOID LEUKEMIA, The New England journal of medicine, 330(12), 1994, pp. 820-825
PROGNOSTIC FACTORS IN CHRONIC MYELOID-LEUKEMIA - RELATIONSHIP WITH INTERFERON AND BONE-MARROW TRANSPLANTATION
Authors: TURA S RUSSO D FANIN R ZUFFA E PATRIARCA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI MD ZACCARIA A MONTEFUSCO E ALIMENA G MELONI G MANDELLI F DAMIANI D MICHIELI M SILVESTRI F VIRGOLINI L CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C DEMILIO A BATTISTA R DITUCCI A BROCCIA G MAJOLINO I CARONIA F LUCIANO L ROTOLI B LEONI P BODENIZZA CA CAROTENUTO M ROTONDO SG NOSARI A DECATALDO F MONTUORO A DELAURENZI A LIBERATI AM TABILIO A MARTELLI M RAMBALDI A BARBUI T LEONI F CIOLLI S RONCA F NOBILE F PAOLINO F RESEGOTTI L PAPINESCHI F SPREMOLLA G LANDOLFI R LEONE G VOLPE E MANGONI L RIZZOLI V CAPUCCI A IZZI T GENTILINI I COSER P GALLO E PILERI A CANTONETTI M PAPA G DINI D DIPRISCO U MORANDI S BIANCHINI E PINOTTI G VENCO A ZAGONEL V PINTO A CAPALDI A GIOVANNELLI E PIZZUTI M RICCIUTI F AMBROSETTI A PERONA G PERRICONE R CAJOZZO A LOMBARDO M TORLONTANO G DELFINI C LUCARELLI G GIRINO M ASCARI E
Citation: S. Tura et al., PROGNOSTIC FACTORS IN CHRONIC MYELOID-LEUKEMIA - RELATIONSHIP WITH INTERFERON AND BONE-MARROW TRANSPLANTATION, Leukemia & lymphoma, 11, 1993, pp. 67-71
WILL MOLECULAR-BIOLOGY CONTRIBUTE TO REFINE PROGNOSIS AND TO SELECT TREATMENT
Authors: ZACCARIA A MARTINELLI G BUZZI M FARABEGOLI P SAGLIO G GUERRASIO A BERNABEI PA SANTINI V PELLICCI PG MENCARELLI A COCO FL DIVERIO D RAMBALDI A SANTORO A TURA S RUSSO D ZUFFA E FANIN R PATRIARCA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI MD ZACCARIA A MONTEFUSCO E ALIMENA G MELONI G MANDELLI F DAMIANI D MICHIELI M CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C DEMILIO A BATTISTA R DITUCCI A BROCCIA G MAIOLINO I CARONIA F LUCIANO L ROTOLI B LEONI P DANIELI G BODENIZZA CA CAROTENUTO M ROTONDO SG NOSARI A DECATALDO F MONTUORO A DELAURENZI A CAMILLO S LIBERATI AM GRIGNANI F TABILIO A MARTELLI M RAMBALDI A BARBUI T LEONI F CIOLLI S RONCA F NOBILE F PAOLINO F RESEGOTTI L PAPINESCHI F SPREMOLLA G LANDOLFI R LEONE G VOLPE E MANGONI L RIZZOLI V CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL GENTILINI I COSER P GALLO E PILERI A CANTONETTI M PAPA G DINI D MORANDI S BIANCHINI E PINOTTI G VENCO A ZAGONEL V PINTO A CAPALDI A GIOVANNELLI E PIZZUTI M RICCIUTI F AMBROSETTI A CAJOZZO A LOMBARDO M TORLONTANO G DELFINI C LUCARELLI G GIRINO M ASCARI E RISSO M DAMASIO E MARTINO S PARDINI S LONGINOTTI M MIRAGLIA E DEBIASE R NARDELLI S GALIENI P DISPENSA E ABBADESSA A BRUZZESE L PROSSOMARITI L CIMINO R DEROSA C GABBAS A FRANCESCO S GALLAMINI A DIFRANCESCO A QUAGLINO D MUSOLINO C SQUADRITO G AVANZINI P GOBBI F NUOVA ASM EMILIA R SAGLIO G AGLIETTA M CAMASCHELLA C MAZZA MU GUGLIELMO P CACCIOLA E MONACO M
Citation: A. Zaccaria et al., WILL MOLECULAR-BIOLOGY CONTRIBUTE TO REFINE PROGNOSIS AND TO SELECT TREATMENT, Leukemia & lymphoma, 11, 1993, pp. 81-89
TREATMENT OF PH-POSITIVE CHRONIC MYELOID-LEUKEMIA WITH ALPHA-INTERFERON (ROFERON-A) - THE ITALIAN COOPERATIVE STUDY-GROUP EXPERIENCE
Authors: TURA S RUSSO D ZUFFA E FANIN R PATRIARCA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI MD ZACCARIA A MONTEFUSCO E ALIMENA G MELONI G MANDELLI F DAMIANI D MICHIELI M CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C DEMILIO A BATTISTA R DITUCCI A BROCCIA G MAIOLINO I CARONIA F LUCIANO L ROTOLI B LEONI P DANIELI G BODENIZZA CA CAROTENUTO M ROTONDO SG NOSARI A DECATALDO F MONTUORO A DELAURENZI A CAMILLO S LIBERATI AM GRIGNANI F TABILIO A RAMBALDI A BARBUI T LEONI F CIOLLI S RONCA F NOBILE F PAOLINO F RESEGOTTI L PAPINESCHI F SPREMOLLA G LANDOLFI R LEONE G VOLPE E MANGONI L RIZZOLI V CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL GENTILINI I COSER P GALLO E PILERI A CANTONETTI M PAPA G DINI D DIPRISCO U MORANDI S BIANCHINI E PINOTTI G VENCO A ZAGONEL V PINTO A CAPALDI A GIOVANNELLI E PIZZUTI M RICCIUTI F AMBROSETTI A PERONA G PERRICONE R CAJOZZO A LOMBARDO M TORLONTANO G DELFINI C LUCARELLI G GIRINO M ASCARI E RISSO M DAMASIO E MARTINO S PARDINI S LONGINOTTI M MIRAGLIA E DEBIASE R NARDELLI S CICCONE F GALIENI P DISPENSA E ABBADESSA A BRUZZESE L PROSSOMARITI L CIMINO R DEROSA C GABBAS A FRANCESCO S GALLAMINI A DIFRANCESCO A QUAGLINO D MUSOLINO C SQUADRITO G AVANZINI P GOBBI F NUOVA ASM EMILIA R SAGLIO G AGLIETTA M CAMASCHELLA C MAZZA MU GUGLIELMO P CACCIOLA E MONACO M
Citation: S. Tura et al., TREATMENT OF PH-POSITIVE CHRONIC MYELOID-LEUKEMIA WITH ALPHA-INTERFERON (ROFERON-A) - THE ITALIAN COOPERATIVE STUDY-GROUP EXPERIENCE, Leukemia & lymphoma, 11, 1993, pp. 153-157
KARYOTYPIC CONVERSION BY INTERFERON AS PREPARATIVE TREATMENT FOR AUTOLOGOUS BMT IN PH POSITIVE CML
Authors: GOBBI M TURA S RUSSO D ZUFFA E PATRIARCA F FIACCHINI M GOBBI M BACCARANI M MONTEFUSCO E MELONI G MANDELLI F ZAMAGNI MD TESTONI N ZACCARIA A FANIN R DAMIANI D MICHIELI M CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V DEMILIO A BATTISTA R DITUCCI A BROCCIA G BODENIZZA CA CAROTENUTO M ROTONDO G AMBROSETTI A PERONA G MAJOLINO I CARONIA F LUCIANO L ROTOLI B MORRA E BERNASCONI C RAMBALDI A BARBUI T RONCO F NOBILE F LEONI P NOSARI A DECATALDO F MONTUORO A DELAURENZI A CAMILLO S GENTILINI I COSER P DINI D DIPRISCO U PAPINESCHI F SPREMOLLA G LIBERATI A GRIGNANI G TABILIO A MARTELLI M PARDINI S LONGINOTTI M MANGONI L RIZZOLI V GALIENI P DISPENSA E ABBADESSA A BRUZZESE L LEONI F CIOLLI S CANTONETTI M PAPA G LANDOLFI R LEONE G GALLO E PILERI A ZAGONEL V PINTO A VOLPE E DIFRANCESCO A QUAGLINO D AVANZINI P GOBBI F PAOLINO F RESEGOTTI L SAGLIO G CAMASCHELLA C MAZZA U PINOTTI G VENCO G CAPUCCI A IZZI T MORANDI S BIANCHINI E SCAPOLI GL MONACO M PIZZUTI M RICCIUTI F CAPALDI A GIOVANNELLI E
Citation: M. Gobbi et al., KARYOTYPIC CONVERSION BY INTERFERON AS PREPARATIVE TREATMENT FOR AUTOLOGOUS BMT IN PH POSITIVE CML, Leukemia & lymphoma, 11, 1993, pp. 277-280
THE ROLE OF RHGM-CSF IN THE CONVENTIONAL POLYCHEMOTHERAPY OF HIGH-GRADE NON-HODGKINS-LYMPHOMA
Authors: ZINZANI PL TURA S PAPA G FANIN R MARTELLI MF GALIENI P LEONE G CHISESI T LISO V DAMMACCO F ROTOLI B MORETTI L CUNEO A VOLPE E GOBBI M CAJOZZO A CALABRESI F MANDELLI F
Citation: Pl. Zinzani et al., THE ROLE OF RHGM-CSF IN THE CONVENTIONAL POLYCHEMOTHERAPY OF HIGH-GRADE NON-HODGKINS-LYMPHOMA, Journal of cellular biochemistry, 1993, pp. 271-271
Risultati: 1-14 |